Millendo Therapeutics, Inc.

Historical 13F Holders

Symbol
MLND
CUSIP
60040X103
All holders as of
Q1 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q1 42 7.08 M $8.50 M
2020 Q4 46 7.72 M $16.5 M
2020 Q3 51 7.91 M $12.9 M
2020 Q2 68 8.44 M $14.8 M
2020 Q1 81 12.6 M $66.6 M
2019 Q4 57 12.2 M $81.9 M
2019 Q3 49 8.10 M $57.6 M
2019 Q2 46 7.85 M $90.7 M
2019 Q1 39 6.97 M $104 M
2018 Q4 43 6.75 M $53.3 M